ARS Pharmaceuticals, Inc.
SPRY
$8.25
-$0.05-0.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.98% | 40.72% | 9.78% | 23.29% | 37.51% |
| Total Receivables | 187.16% | 2,942.29% | 4,712.18% | 1,562.46% | 1,237.46% |
| Inventory | 60.57% | 988.39% | -- | -- | -- |
| Prepaid Expenses | -11.76% | 197.13% | 366.91% | 734.87% | 190.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 84.66% | 307.85% | 14.92% | -- |
| Total Current Assets | -14.78% | 62.30% | 27.50% | 34.31% | 44.26% |
|
|
|||||
| Total Current Assets | -14.78% | 62.30% | 27.50% | 34.31% | 44.26% |
| Net Property, Plant & Equipment | 131.24% | 183.21% | 237.47% | 40.91% | 29.37% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 96.07% | 88.57% | -- | -- | 1,094.65% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 206.84% | -- | 3,540.58% | 2,706.63% | 40,000.00% |
| Total Assets | -6.69% | 71.32% | 41.23% | 43.82% | 50.59% |
|
|
|||||
| Total Accounts Payable | -35.12% | 1.28% | 391.99% | 891.66% | 1,761.00% |
| Total Accrued Expenses | 306.35% | 242.77% | 248.00% | 322.75% | 592.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 471.57% | 268.13% | -66.36% | -- |
| Total Finance Division Other Current Liabilities | 191.33% | 1,379.35% | 8,039.29% | 4,038.14% | 559.25% |
| Total Other Current Liabilities | 191.33% | 1,379.35% | 8,039.29% | 4,038.14% | 559.25% |
| Total Current Liabilities | 67.00% | 206.06% | 578.05% | 643.53% | 880.34% |
|
|
|||||
| Total Current Liabilities | 67.00% | 206.06% | 578.05% | 643.53% | 880.34% |
| Long-Term Debt | 142.88% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 274.35% | -- | -- | -- | -- |
| Total Liabilities | 126.16% | 1,254.44% | 1,701.50% | 2,547.21% | 3,786.12% |
|
|
|||||
| Common Stock & APIC | 7.60% | 7.24% | 6.77% | 5.62% | 4.94% |
| Retained Earnings | -138.92% | -46.20% | -31.16% | -11.05% | 6.09% |
| Treasury Stock & Other | -43.18% | -102.06% | 68.28% | 158.06% | 348.98% |
| Total Common Equity | -55.51% | -26.53% | -10.65% | 2.28% | 11.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.51% | -26.53% | -10.65% | 2.28% | 11.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.51% | -26.53% | -10.65% | 2.28% | 11.28% |
|
|
|||||